June 14, 2024 Release Highlights Copied

Practice Insights is pleased to announce updates in the application to support the Merit-Based Incentive Payment System (MIPS), the NCCN Distress Thermometer, and Advance Care Planning (ACP).

MIPS Quality Measures Dashboard

• PIMSH #15: Antiemetic Therapy for Low- and Minimal-Emetic-Risk Antineoplastic Agents in the Infusion Center – Avoidance of Overuse (inverse) and PIMSH #16: Appropriate Antiemetic Therapy for High- and Moderate-Emetic-Risk Antineoplastic Agents in the Infusion Center have been updated to attribute patients to their attending provider after further discussion with the measure steward ASCO.
  • Originally, patients were attributed to the most recently documented provider in line with previous guidance. This led to patients being attributed to clinicians who are not necessarily responsible for the patient’s treatment decisions.
• The dashboard has also been updated to display all i-Sections. Previously, the links were not accessible, and practices were utilizing the documentation provided.
• The dashboard has also been updated to include a new measure, MIPS #487: Screening for Social Drivers of Health as detailed below.
  • The electronic version of the NCCN Distress Thermometer available in Ontada Health and the iKnowMed Patient Hx tab will be used to calculate MIPS #487. If the patient submits the NCCN Distress Thermometer through Ontada Health or a practice user documents the NCCN Distress Thermometer in iKnowMed, either would be considered for the measure.
  • The documentation is only complete when a distress score is entered, or any concerns are documented. The measure intends to ensure screening is performed, so charting by exception meets the intent.

  Measure	Specification	Numerator and Denominator
  MIPS #487: Screening for Social Drivers of Health	A percentage of patients 18 years and older screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety.	Numerator: Number of patients 18 years and older screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety. Denominator: Number of patients 18 years and older with an encounter during the performance period. Exclusions: The patient declined screening.

NCCN Distress Thermometer Dashboard

Starting Monday, June 17, 2024, the NCCN Distress Thermometer dashboard will be updated to include the last two weeks of data from May 18, 2024, to May 31, 2024.

Advance Care Planning Dashboards

Starting Monday, June 17, 2024, you can view final data from Q1 2024 using the Time Period drop-down on the Advance Care Planning Performance and Advance Care Planning Activities dashboards.

Status of Dashboard Updates for 2024

CMS releases updates to the quality measure specifications annually for the MIPS program. These measure specifications have been reviewed, and Practice Insights is working on the required technical updates to align with the revised requirements. McKesson will continue to notify practices once measures have been updated based on the current 2024 requirements. The measures listed below either have no 2024 update required or have been updated.

Measure	Description
MIPS Quality Measures Dashboard
#128	BMI (This measure is no longer a MIPS Traditional Measure)
#130	Current Medications
#134 (eCQM Version)	Preventive Care and Screening for Depression and Follow-Up Plan
#143	Pain Intensity Quantified
#374	Closing the Referral Loop
#462	Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy
#487	Social Drivers of Health
PIMSH#1	Advance Care Planning in Stage 4 Disease
PIMSH#2	Utilization of GCSF in Metastatic Colon/Rectal Cancer (Inverse Measure)
PIMSH#4	Patient-Reported Pain Improvement
PIMSH#9	Supportive Care Drug Utilization in the Last 14 Days of Life (Inverse Measure)
PIMSH#10	Hepatitis B Serology Testing for Prophylactic Treatment Prior to Receiving Anti-CD20 Targeting Drugs
PIMSH#15	Antiemetic Therapy for Low-and-Minimal-Emetic Risk Antineoplastic Agents in the Infusion Center-Avoidance of Overuse (Inverse Measure)
PIMSH#16	Appropriate Antiemetic Therapy for High-and Moderate-Emetic-Risk Antineoplastic Agents in the Infusion Center